Transpact Enterprises Ltd.
BBSE:TRANSPACT99.16
INR
+4.72
(+5.00%)
ISIN
INE06YD01010
Return %
Stock
S&P 500
1Y
-58.00
14.20
3Y
-68.40
81.12
5Y
-38.26
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Raman Talwar
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Mumbai India
- IPO Date
- Sep 6, 2019
- Website
- transpact.in
- Similar Companies
- Business
- Transpact Enterprises Ltd. is an India-based medical technology and corporate consulting company engaged in the design, development, manufacturing, and commercialization of specialized therapeutic devices, clinical software platforms, and commercial advisory services. Founded in May 2013 and incubated at the Society for Innovation and Entrepreneurship (SINE) at the Indian Institute of Technology (IIT) Bombay, the company is headquartered in Mumbai, Maharashtra, and provides its products and services across India with distribution channels extending to international rehabilitation and healthcare markets. The company operates primarily across two business divisions: Medical Technologies & Healthcare Solutions and Corporate Advisory Services. Its core healthcare product portfolio comprises the Vestibulator, a mechanized, multi-directional therapeutic device co-patented with IIT Bombay that provides vestibular, neurodevelopmental, and sensory integration therapy for individuals with cerebral palsy, autism spectrum disorder, attention deficit hyperactivity disorder, and balance dysfunctions; the Vestibulator Chair, a compact ergonomic therapy seating system developed for home healthcare and decentralized rehabilitation; and RehabSoft, a cloud-based rehabilitation and clinic management software suite featuring electronic health records, therapy scheduling, individualized exercise and nutrition regimen monitoring, and blockchain-secured patient data management. Complementing its medical line, the company provides corporate consulting solutions; project appraisal and debt structuring; corporate finance and strategic advisory; portfolio management consulting; and capital market advisory services. Transpact Enterprises serves a client base that includes multi-specialty hospitals, neuro-rehabilitation clinics, pediatric therapy institutions, special education schools, private caregivers, and corporate entities. In recent corporate developments, Transpact Enterprises has executed strategic governance and executive management changes, including the transition of its Chief Financial Officer, the appointment of a new Company Secretary and Compliance Officer, and the engagement of new statutory and secretarial auditors to optimize regulatory compliance and internal reporting. The company has also reconstituted its board of directors to enhance independent oversight and expand female representation at the board level. Operationally, the company continues to execute on the clinical integration of its cloud-enabled RehabSoft platform with its installed base of therapeutic hardware to drive recurring service revenues, while expanding commercial distribution across healthcare institutions and institutional therapy networks.